Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1428
HR+
Luminal
QNZ
NFkB
NFKB
7442.096
uM
0.05133
0.03292
0.2055 0.2115 1.2374 0.4267
0.9952
0.7665
HCC1428
HR+
Luminal
Ribavirin
15350.211
uM
inf
inf
0.8894 0.8894 0.0000 0.0337
0.3498
1.0306
HCC1428
HR+
Luminal
SB-3CT
MMP2/9
MMP
11936.144
uM
inf
inf
0.7149 0.7149 0.0000 0.1094
0.4821
0.8864
HCC1428
HR+
Luminal
SB-3CT
MMP2/9
MMP
10693.144
uM
32.03330
61.42970
-0.3902 -1.0000 1.6873 0.1276
0.9857
0.8585
HCC1428
HR+
Luminal
Selumetinib
MEK
MAPK
11936.155
uM
inf
inf
1.0472 1.0472 0.0000 -0.0048
-0.0036
0.7332
HCC1428
HR+
Luminal
Selumetinib
MEK
MAPK
10693.146
uM
inf
inf
0.8351 0.8351 0.0000 0.0516
0.1098
0.8826
HCC1428
HR+
Luminal
Sigma A6730
AKT
AKT
11936.158
uM
3.38090
9.20560
-0.9891 -1.0000 1.0968 0.4375
0.9221
0.7417
HCC1428
HR+
Luminal
Sigma A6730
AKT
AKT
10693.153
uM
3.63940
9.60190
-0.9834 -1.0000 1.1324 0.3920
0.9640
0.8137
HCC1428
HR+
Luminal
Sirolimus
MTOR
MTOR
7441.068
uM
0.05063
0.43912
-0.0852 -0.3113 0.2241 0.6254
0.8277
0.7801
HCC1428
HR+
Luminal
Sirolimus
MTOR
MTOR
7444.069
uM
0.04448
1.09320
-0.1444 -0.5261 0.2245 0.5395
0.9188
0.9426
HCC1428
HR+
Luminal
Sirolimus
MTOR
MTOR
7443.068
uM
0.04387
0.01554
0.1983 0.3198 0.9833 0.4791
0.9312
1.1167
HCC1428
HR+
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7444.084
uM
inf
inf
0.3255 0.3255 0.0000 0.1199
0.2928
0.8647
HCC1428
HR+
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7443.084
uM
28.18330
32.83130
-0.7404 -0.5726 5.0000 0.4589
0.9738
0.9878
HCC1428
HR+
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7442.085
uM
92.66040
146.47610
-0.7588 -1.0000 2.3991 0.1857
0.9848
0.8237
HCC1428
HR+
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7441.084
uM
40.75420
62.57180
-0.9676 -0.9832 2.5361 0.4415
0.9942
0.8431
HCC1428
HR+
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7441.067
uM
4.44990
8.2370
-0.9974 -1.0000 1.7842 0.5285
0.9786
0.8233
HCC1428
HR+
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7443.067
uM
5.72730
8.93080
-0.9909 -1.0000 2.4729 0.5168
0.9844
1.0344
HCC1428
HR+
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7442.067
uM
5.55930
8.32030
-0.9894 -1.0000 2.7245 0.5335
0.9853
0.9126
HCC1428
HR+
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7444.067
uM
5.56940
8.47330
-0.9996 -1.0000 2.6181 0.4675
0.9936
0.7382
HCC1428
HR+
Luminal
TAPI-0
TACE/Collagenase
7442.096
uM
37.80890
407.90930
0.5074 -1.0000 0.4619 0.1032
0.9606
0.7665
HCC1428
HR+
Luminal
Taxol
TUBB
TUBB
10031.002
uM
inf
0.01672
0.4898 0.5157 1.5331 0.2758
0.9802
0.6483
HCC1428
HR+
Luminal
Taxol
TUBB
TUBB
9294.002
uM
0.01980
0.01237
0.1991 0.2343 1.3450 0.4594
0.9887
0.7467
HCC1428
HR+
Luminal
TCS 2312
CHK1
CHK
11936.159
uM
0.66227
1.12950
-0.9852 -0.9812 2.0341 0.5428
0.9903
0.7472
HCC1428
HR+
Luminal
TCS 2312
CHK1
CHK
10693.152
uM
0.71115
1.24860
-0.8598 -0.8990 1.8279 0.5340
0.9917
0.8734
HCC1428
HR+
Luminal
TCS PIM-1 1
Pim kinase
PIM
11936.135
uM
74.19980
410.43960
0.3382 -1.0000 0.6423 0.1138
0.9279
0.8584